About Serenity
Founded in 2006 and based in Miami, United States, Serenity operates in the biopharmaceutical sector. Therapeutics addressing voiding disorders are developed, with a focus on nocturia treatments. The product Noctiva, a desmopressin acetate nasal spray, is indicated for adults experiencing nocturnal polyuria. Operations center on research and development of such specialized medical solutions.
- Headquarter Miami, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Acerus Pharma
& 1 more
-
Employee Count
Not available
-
Acquired by
Acerus Pharma
(Feb 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Serenity
Investors in Serenity
Serenity has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Acerus Pharma and HUD Exchange.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments.
|
Locked | Locked | Locked |
Investor details for Serenity
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Serenity
Investment portfolio details for Serenity
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Serenity
Detailed financials for Serenity
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Serenity Comparisons
Peer comparison for Serenity
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Serenity
Detailed competitors of Serenity
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Serenity
Complete news archive for Serenity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serenity
Serenity was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Serenity is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Founded in 2006 and based in Miami, United States, Serenity operates in the biopharmaceutical sector. Therapeutics addressing voiding disorders are developed, with a focus on nocturia treatments. The product Noctiva, a desmopressin acetate nasal spray, is indicated for adults experiencing nocturnal polyuria. Operations center on research and development of such specialized medical solutions.
Serenity has 2 investors. Key investors include Acerus Pharma, and HUD Exchange.